Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 10—October 2011
Dispatch

Antimicrobial Ointments and Methicillin-Resistant Staphylococcus aureus USA300

Masahiro SuzukiComments to Author , Kazuhiro Yamada, Miki Nagao, Etsuko Aoki, Masakado Matsumoto, Tatsuya Hirayama, Hiroaki Yamamoto, Reiji Hiramatsu, Satoshi Ichiyama, and Yoshitsugu Iinuma
Author affiliations: Author affiliations: Aichi Prefectural Institute of Public Health, Nagoya, Japan (M. Suzuki, K. Yamada, M. Matsumoto, T. Hirayama, H. Yamamoto, R. Hiramatsu); Kyoto University Hospital, Kyoto, Japan (M. Nagao, S. Ichiyama, Y. Iinuma); Kyoto University, Kyoto (M. Nagao, S. Ichiyama, Y. Iinuma); National Hospital Organization Nagoya Medical Center, Nagoya (E. Aoki); Kanazawa Medical University, Kahoku, Japan (Y. Iinuma)

Main Article

Table 2

Bacitracin and neomycin susceptibility of MRSA USA300 and other MRSA isolates*

Bacitracin/neomycin
MRSA USA300 (MICs of bacitracin, neomycin, and polymyxin B)† Other MRSA
Kyoto University Hospital
Nagoya Medical Center
ATCC type strains
R/R 9 (400, 128, 200–400) 0 BAA1717 (400, 128, 400) 0
R/S 0 1 (400, 0.25, 400) 0
S/R 0 0 11
I/S 0 0 1
S/I 0 0 132
S/S
9 (6.25–12.5, 0.25, 400)
0
BAA1556 (6.25, 0.25, 400)
96
Total 18 1 2 240

*MRSA, methicillin resistant Staphylococcus aureus; ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S, susceptible; I, intermediate resistance.
†MICs are expressed as units/mL for bacitracin and polymyxin B and in μg/mL for neomycin.

*MRSA, methicillin resistant Staphylococcus aureus; ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S, susceptible; I, intermediate resistance.
†MICs are expressed as units/mL for bacitracin and polymyxin B and in μg/mL for neomycin.

*MRSA, methicillin resistant Staphylococcus aureus; ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S, susceptible; I, intermediate resistance.
†MICs are expressed as units/mL for bacitracin and polymyxin B and in μg/mL for neomycin.

*MRSA, methicillin resistant Staphylococcus aureus; ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S, susceptible; I, intermediate resistance.
†MICs are expressed as units/mL for bacitracin and polymyxin B and in μg/mL for neomycin.

*MRSA, methicillin resistant Staphylococcus aureus; ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S, susceptible; I, intermediate resistance.
†MICs are expressed as units/mL for bacitracin and polymyxin B and in μg/mL for neomycin.

Main Article

Page created: September 22, 2011
Page updated: September 22, 2011
Page reviewed: September 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external